EUVIMEDEUVIMED entdecken
Crossref

Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer

Lili Xu, Tomohito Sato, Chi Zhang, Ryo Omagari, Yutaka Takahashi, Atsushi Baba, Shoshiro Hirayama, Tomohiro Matsumoto, Ryoma Haneda, Wataru Soneda, Eisuke Booka, Yuki Sakai und 9 weitere

Gastric Cancer · 2026-11 · 29 (6) · 1247-1257

DOI: 10.1007/s10120-026-01807-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 22.10.2026. Verfasst von Lili Xu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Peritoneal Lavage, Biomarkers, Tumor, Neoplasm Recurrence, Local. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, BRAIN, Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritoneal dissemination accounts for more than 40% of recurrences after radical gastrectomy for gastric cancer. Although peritoneal lavage cytology (CY) is routinely used to detect intraperitoneal free cancer cells, peritoneal recurrence still occurs in a subset of CY-negative patients. Novel molecular biomarkers are urgently needed to identify high-risk individuals within this cohort.

Methods

Direct flow injection quadrupole time-of-flight mass spectrometry (DFI-Q-TOF-MS) in negative ion mode was applied to profile peritoneal lavage supernatants from gastric cancer patients stratified by recurrence outcome (CY-R + vs. CY-R−). Candidate recurrence-associated features were selected by volcano plot, LASSO logistic regression, and Random Forest. PLS-DA with VIP scores was applied for stage-associated feature identification.

Results

A recurrence-associated lipid signature was identified comprising phosphatidylethanolamine species (PE (34:0), PE (34:1), PE (38:1), PE O-38:5), phosphatidic acid PA (39:3), phosphatidylinositol PI (22:1), and oxidized sphingoid base SPB (18:3;O2), implicating membrane remodeling, lipid signaling pathway alterations, and oxidative stress in the peritoneal microenvironment of recurrence-prone patients.

Conclusion

This study presents an exploratory lipidomic characterization of peritoneal lavage supernatant in CY-negative gastric cancer, identifying hypothesis-generating candidate lipid features associated with recurrence status. Given the small recurrence group and absence of external validation, all findings should be interpreted as exploratory and require confirmation in prospective multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsPeritoneal LavageBiomarkers, TumorNeoplasm Recurrence, LocalLipidomicsPeritoneal NeoplasmsPhosphatidylethanolaminesPhosphatidylinositolsHumansFemaleMaleMiddle AgedAgedPrognosis

Stichwörter der Autor:innen

Candidate biomarkersGastric cancerLipidomicsMass spectrometryPeritoneal RecurrencePeritoneal lavage

Substanzen

Biomarkers, TumorPhosphatidylethanolaminesPhosphatidylinositolsphosphatidylethanolamine

Autor:innen und Institutionen

  • Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Department of Surgery, Shimada Municipal Hospital, 1200-5, Noda, Shimada, Shizuoka, Japan.
  • Department of Perioperative Functioning Care and Support, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Quantum Imaging Laboratory, Division of Research and Development in Photonics Technology/International Mass Imaging and Spatial Omics Center, Institute of Photonics Medicine, Hamamatsu University School of Medicine, Ham…
  • Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. setou@hama-med.ac.jp.

Förderung

  • Japan Society for the Promotion of Science
  • BRAIN
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Xu, L., Sato, T., Zhang, C., Omagari, R., Takahashi, Y., Baba, A., Hirayama, S., Matsumoto, T., Haneda, R., Soneda, W., Booka, E., Sakai, Y., Murakami, T., Watanabe, T., Sato, M., Kikuchi, H., Yohshiriro, H., Kahyo, T., Okamoto, K., …, & Setou, M. (2026). Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer. Gastric Cancer, 29(6), 1247-1257. https://doi.org/10.1007/s10120-026-01807-x

Vancouver

Xu L, Sato T, Zhang C, Omagari R, Takahashi Y, Baba A, et al. Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer. Gastric Cancer. 2026;29(6):1247-1257. doi:10.1007/s10120-026-01807-x

BibTeX
@article{Xu2026,
  author = {Xu, Lili and Sato, Tomohito and Zhang, Chi and Omagari, Ryo and Takahashi, Yutaka and Baba, Atsushi and Hirayama, Shoshiro and Matsumoto, Tomohiro and Haneda, Ryoma and Soneda, Wataru and Booka, Eisuke and Sakai, Yuki and Murakami, Tomohiro and Watanabe, Takahiro and Sato, Masanori and Kikuchi, Hirotoshi and Yohshiriro, Hiramatsu and Kahyo, Tomoaki and Okamoto, Kazuma and Takeuchi, Hiroya and Setou, Mitsutoshi},
  title = {Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer},
  journal = {Gastric Cancer},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {1247--1257},
  doi = {10.1007/s10120-026-01807-x}
}
Kostenlos starten →